Xuan-Sheng Ding Selected Research

caffeine citrate

1/2021	Caffeine Therapy for Apnea of Prematurity: Role of the Circadian CLOCK Gene Polymorphism.
1/2021	Caffeine for the Pharmacological Treatment of Apnea of Prematurity in the NICU: Dose Selection Conundrum, Therapeutic Drug Monitoring and Genetic Factors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xuan-Sheng Ding Research Topics

Disease

8	Fibrosis (Cirrhosis) 01/2021 - 01/2018
4	Neoplasms (Cancer) 01/2022 - 01/2017
3	Nephrotic Syndrome (Syndrome, Nephrotic) 04/2020 - 01/2018
3	Body Weight (Weight, Body) 04/2020 - 01/2017
2	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2022 - 01/2019
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2016
2	Epilepsy (Aura) 01/2021 - 01/2020
2	Apnea 01/2021 - 01/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021
1	Anemia 10/2019
1	Hemorrhage 01/2019
1	Aspergillosis 12/2018
1	Diabetic Cardiomyopathies 11/2018
1	Glomerulonephritis 01/2018
1	Carcinogenesis 08/2017
1	Neoplasm Metastasis (Metastasis) 08/2017
1	Lung Neoplasms (Lung Cancer) 01/2016
1	Adenocarcinoma of Lung 01/2016
1	Diabetic Nephropathies (Diabetic Nephropathy) 09/2013

Drug/Important Bio-Agent (IBA)

4	Pharmaceutical PreparationsIBA 01/2022 - 10/2019
3	Tacrolimus (Prograf)FDA LinkGeneric 04/2020 - 01/2018
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2016
3	MicroRNAs (MicroRNA)IBA 11/2018 - 08/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 10/2020
2	Androgen Receptors (Androgen Receptor)IBA 01/2021 - 10/2020
2	Caffeine (No Doz)FDA LinkGeneric 01/2021 - 01/2021
2	Valproic Acid (Depakote)FDA LinkGeneric 01/2021 - 01/2020
2	caffeine citrate FDA LinkGeneric 01/2021 - 01/2021
2	Cytochrome P-450 CYP3AIBA 04/2020 - 01/2018
1	Dexmedetomidine FDA Link 01/2022
1	Gefitinib (Iressa)FDA Link 01/2022
1	CholesterolIBA 01/2022
1	Propofol (Diprivan)FDA LinkGeneric 01/2022
1	Midazolam (Versed)FDA LinkGeneric 01/2022
1	Fenofibrate (CiL)FDA LinkGeneric 01/2022
1	Biological ProductsIBA 01/2021
1	MethyltransferasesIBA 01/2021
1	CytokinesIBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2021
1	HomocysteineIBA 10/2020
1	Long Noncoding RNAIBA 10/2020
1	growth arrest specific transcript 5IBA 10/2020
1	TabletsIBA 01/2020
1	SolutionsIBA 01/2020
1	Dosage Forms (Dosage Form)IBA 01/2020
1	Cefoperazone (Cefoperazone Sodium)FDA Link 10/2019
1	Hemoglobins (Hemoglobin)IBA 10/2019
1	Ibuprofen (Motrin)FDA LinkGeneric 10/2019
1	Sulbactam FDA LinkGeneric 10/2019
1	Fluconazole (Zonal)FDA LinkGeneric 10/2019
1	cefathiamidineIBA 10/2019
1	Vancomycin FDA LinkGeneric 10/2019
1	Diltiazem (Cardizem)FDA LinkGeneric 04/2019
1	Pyruvic Acid (Pyruvate)IBA 01/2019
1	salicylhydroxamic acid (SHAM)IBA 12/2018
1	TriazolesIBA 12/2018
1	Voriconazole (Vfend)FDA LinkGeneric 12/2018
1	Proteins (Proteins, Gene)FDA Link 11/2018
1	Calcineurin InhibitorsIBA 01/2018
1	Histones (Histone)IBA 01/2018
1	Extracellular Matrix ProteinsIBA 01/2018
1	Urea (Carbamide)FDA LinkGeneric 01/2017
1	CreatinineIBA 01/2017
1	Huang QiIBA 01/2017
1	HDL CholesterolIBA 01/2016
1	ErbB Receptors (EGF Receptor)IBA 01/2016
1	Tyrosine Kinase InhibitorsIBA 01/2016
1	Collagen Type IV (Type IV Collagen)IBA 09/2013
1	icariinIBA 09/2013
1	Transforming Growth Factors (Transforming Growth Factor)IBA 09/2013

Therapy/Procedure

4	Therapeutics 01/2021 - 08/2017
2	Drug Therapy (Chemotherapy) 01/2021 - 01/2016
1	Injections 01/2017